Time-restricted Eating and High-intensity Interval Training After Gestational Diabetes
TRE-HIITmoms
TRE-HIITmoms
Sponsor study identifier
interventional
56
1 country
1
Study Start
November 1, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Primary Completion
December 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
January 2029
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
This trial will recruit participants who had gestational diabetes in their most previous pregnancy. Participants will be randomly allocated into two groups: one intervention group and one control group 6-12 weeks after giving birth. The intervention group will undergo an 8-week supervised intervention consisting of time-restricted eating and endurance exercise training with moderate-to-high intensity. The investigators will assess cardiorespiratory fitness, body composition, and other markers of cardiovascular and metabolic health before and after the 8 weeks. Additionally, the participants in the intervention group will be encouraged to continue exercising and eating time restricted after the supervised period and follow them up by telephone until one year from the baseline visit. The investigators will measure the same outcomes at the follow-up as on the previous two test points.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2029
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 3, 2026
Actual (reported)August 20, 2026
Actual (reported)November 1, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
December 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
January 2029
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Peak oxygen uptake
Direct measurement of oxygen uptake during graded maximal exercise test to exhaustion
From baseline to after 8 weeks
Peak oxygen uptake
From baseline to after 12 months
Body mass
From baseline to after 8 weeks
Body mass
From baseline to after 12 months
Fat mass
From baseline to after 8 weeks
Fat mass
From baseline to after 12 months
Infant feeding method
Baseline, 8 weeks, and after 12 months
Adherence to time-restricted eating
Baseline, after 8 weeks and after 12 months
Adherence to exercise training
During the 8-week intervention and during the 12-month follow-up
Time-restricted eating and high-intensity interval training
No intervention administered
The intervention is a combination of time-restricted eating and endurance exercise training. Time-restricted eating implies that the participants will be asked to limit their energy intake to a maximum 10-hour time window daily. The endurance exercise programme consists of 2-4 weekly supervised exercise sessions for 8 weeks. Thereafter, the participants will continue exercising unsupervised with weekly follow-up from researchers.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Department of Circulation and Medical Imaging
Trondheim, 7491, Norway
Trine Moholdt, PhD
Norwegian University of Science and Technology
First Submitted
July 3, 2026
First Posted
August 20, 2026
Study Start
November 1, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Primary Completion
December 2028
EstimatedContact the study team to confirm eligibility.
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
January 2029
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
October 15, 2026
Record last verified: 2026-10
We will make de-identified individual participant data (IPD) collected in the study available to other researchers. We will upload a data set in an open access repository. We will only share IPD that cannot be used to identify individuals.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: